Widely used:Recently Viewed
Clear AllQuality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$70 Mln
P/E Ratio
--
P/B Ratio
10.02
Industry P/E
--
Debt to Equity
0.07
ROE
-1.61 %
ROCE
-152.25 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-60.44 Mln
EBITDA
$-66.94 Mln
Net Profit
$-69.62 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
IceCure Medical (ICCM)
| 10.91 | 10.41 | 0.00 | 1.67 | -18.21 | -- | -- |
|
BSE Sensex*
| 2.54 | 3.64 | 5.71 | 8.82 | 11.73 | 20.10 | 11.34 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
|
|---|---|---|---|
|
IceCure Medical (ICCM)
| -30.97 | -49.18 | 1,119.02 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 14.26 | 1,100.83 | 7.21 | 24.31 | |
| 0.62 | 16.24 | -- | -0.22 | |
| 5.15 | 339.21 | -- | -31.35 |
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system... for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Read more
CEO & Director
Mr. Eyal Shamir
CEO & Director
Mr. Eyal Shamir
Headquarters
Caesarea
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of IceCure Medical Ltd (ICCM) stood at $ 13 Mln as on 31-Dec-24
The share price of IceCure Medical Ltd (ICCM) is $1.22 (NASDAQ) as of 28-Apr-2025 16:00 EDT. IceCure Medical Ltd (ICCM) has given a return of -18.21% in the last 3 years.
IceCure Medical Ltd (ICCM) has a market capitalisation of $ 70 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of IceCure Medical Ltd (ICCM) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the IceCure Medical Ltd (ICCM) and enter the required number of quantities and click on buy to purchase the shares of IceCure Medical Ltd (ICCM).
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
The CEO & director of Mr. Eyal Shamir. is IceCure Medical Ltd (ICCM), and CFO & Sr. VP is Mr. Eyal Shamir.
There is no promoter pledging in IceCure Medical Ltd (ICCM).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
142
|
|
|
44
|
|
|
2
|
|
|
142
|
| IceCure Medical Ltd. (ICCM) | Ratios |
|---|---|
|
Return on equity(%)
|
-160.7
|
|
Operating margin(%)
|
-476.94
|
|
Net Margin(%)
|
-465.45
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of IceCure Medical Ltd (ICCM) was $0 Mln.
$0.02
(
